The basal ganglia system is an important area in the human brain which plays a major role in controlling movement and behavior. It is composed of several structures including the striatum, globus pallidus, and the substantia nigra. These structures are responsible for initiating, controlling, and modulating different aspects of motor behavior, learning, and memory. The striatum is the most significant part of the basal ganglia system. It is composed of neurons that send messages from the cerebral cortex to the thalamus and to other parts of the brain. In addition to sending messages, the striatum also modulates incoming signals from the thalamus and other parts of the brain. This regulation allows us to smoothly execute actions. The globus pallidus is comprised of two large clusters of neurons. These neurons act as the input center of the basal ganglia and transmit signals from the thalamus to the striatum. The globus pallidus plays a crucial role in motor control, and is responsible for coordinating and integrating motor movements with cognitive processes. The substantia nigra is a region of the midbrain that is important for the regulation of movement. It receives signals from the striatum and the globus pallidus, and sends out signals to the nervous system in order to activate, deactivate, and modify motor movements. The substantia nigra also sends signals to the thalamus, which helps with the regulation of various cognitive functions. The basal ganglia system plays an important role in controlling movement and behavior, and its activity is regulated by numerous neurological and psychological factors. Damage or dysfunction to any of the components of the basal ganglia system can result in impaired motor control, cognitive deficits, and behavioral disturbances. For this reason, it is important to understand the workings of the basal ganglia system in order to develop effective therapeutic strategies for neurological and psychological conditions.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom